Fact-checked by Grok 2 weeks ago

Stenosis

Stenosis is a medical condition characterized by the abnormal narrowing of a passageway or channel in the body, such as vessels, heart valves, the , or digestive tracts, which impedes the normal flow of substances like , air, or . This narrowing can occur in various anatomical locations and may result from degenerative changes, , injury, or congenital factors, often leading to impaired function of affected organs or tissues. Common types of stenosis include , where the heart's narrows and restricts blood flow from the left ventricle to the ; , involving the compression of the or nerves due to narrowing of the ; , caused by plaque buildup that blocks blood flow to the brain; and tracheal or esophageal stenosis, which affects breathing or swallowing. Causes vary by type but frequently involve (plaque accumulation in arteries), chronic inflammation from conditions like , post-surgical scarring, infections, or age-related degeneration of tissues. Symptoms depend on the location and severity; for instance, vascular stenosis may cause , , or risk, while often presents with , numbness, or leg weakness during activity. Diagnosis typically involves imaging techniques such as MRI, CT scans, ultrasound, or angiography to visualize the narrowing, alongside physical examinations and patient history. Treatment options range from conservative measures like medications to relieve symptoms or lifestyle modifications, to interventional procedures including balloon angioplasty, stent placement, or surgical interventions such as valve replacement or decompression surgery, aimed at restoring normal flow and alleviating pressure. Early detection and management are crucial, as untreated stenosis can lead to serious complications like heart failure, paralysis, or organ damage, though many cases can be effectively managed with timely intervention.

Overview

Definition

Stenosis refers to the abnormal narrowing of a tubular structure or passageway in the body, such as a , duct, or , which restricts the normal flow of fluids, gases, or other contents through it. This condition can impair physiological functions depending on the affected site, leading to symptoms like , reduced organ , or obstruction-related complications. The term "stenosis" originates from the Greek word stenos, meaning "narrow," combined with the suffix -osis indicating a pathological condition, entering medical usage via New Latin in the mid-19th century. It is often used interchangeably with "stricture," though stricture may specifically denote a more fibrotic or scarred narrowing, while stenosis is a broader term encompassing various forms of constriction. Unlike occlusion, which implies complete blockage of the passageway, stenosis involves partial narrowing that allows some flow to persist. Additionally, stenosis may present as focal, involving a localized segment, or diffuse, affecting a longer or more extensive portion of the structure. Common anatomical sites affected by stenosis include arteries, heart valves, the , the , and the , among others, where the narrowing can arise from diverse underlying processes.

In developed countries, valvular stenosis, particularly , is a leading form, affecting approximately 12.4% of individuals over 75 years with any degree of aortic stenosis and 3.4% with severe cases. The incidence of severe remains stable at around 52.5 cases per 100,000 patient-years, with rates escalating dramatically with age—from fewer than 50 per 100,000 in those aged 25–49 years to over 1,300 per 100,000 in those 80 years or older. For spinal stenosis, primarily lumbar, the prevalence in the general population based on clinical diagnosis averages 11% (95% CI: 4–18%), rising to 25% among primary care patients and affecting about 1 in 1,000 people over 65 years and 5 in 1,000 over 50 years. Degenerative forms show a prevalence range of 1.7–13.1%, with moderate stenosis occurring in 21–30% and severe cases in 6–7% of older adults. Vascular stenosis, such as carotid artery stenosis, is less common overall, with a general population prevalence of about 3%; severe asymptomatic cases affect 0.1% of men under 50 years, increasing to 3.1% in those 80 years or older, and similar patterns in women. Prevalence of greater than 50% carotid stenosis reaches 7.4% in select cohorts. Globally, the prevalence of carotid artery stenosis is estimated at 1.5% in adults aged 30–79 years, with higher burdens in regions with elevated cardiovascular risk factors. Demographic trends highlight age as the predominant factor across degenerative stenoses, with elderly populations bearing the highest burden; for instance, is more prevalent in men, while shows no strong gender disparity but increases steadily after age 40. Racial variations exist, particularly in vascular forms, where high-grade carotid stenosis is less common in Black and Hispanic individuals compared to Whites, and higher in . Geographic patterns reflect lifestyle and atherosclerosis risks, with higher vascular stenosis rates in Western countries due to elevated prevalence of contributing factors like and sedentary behavior, alongside regional treatment disparities in the United States. In developing regions, infectious and congenital factors may contribute more to certain stenosis types. Key risk factors for stenosis include advanced age, which universally amplifies incidence across types; , which independently elevates the risk of carotid and ; and , often compounding effects with to promote vascular narrowing. These factors contribute to the overall population-level burden without specifying underlying mechanisms.

Types

Valvular Stenosis

Valvular stenosis refers to the narrowing of one or more of the heart's four valves, which impedes blood flow and disrupts normal cardiac circulation. The , located between the right atrium and right ventricle, consists of three leaflets and functions to allow unidirectional blood flow from the atrium to the ventricle while preventing backflow during ventricular contraction. The , positioned between the right ventricle and the , also has three leaflets and opens to permit deoxygenated blood to enter the lungs for oxygenation, closing to avoid reflux into the ventricle. The , situated between the left atrium and left ventricle, features two leaflets and ensures forward flow of oxygenated blood into the ventricle, sealing to maintain pressure during . Finally, the , between the left ventricle and , comprises three leaflets (or two in bicuspid variants) and facilitates ejection of blood to the systemic circulation while blocking retrograde flow. These semilunar and atrioventricular valves operate through passive opening and pressure-driven closure, supported by and papillary muscles in the case of the tricuspid and mitral valves. Among the subtypes, is the most prevalent form of valvular stenosis, affecting approximately 9.4 million people globally in 2019, with prevalence rising sharply with age to 9.8% in those 80-89 years old, primarily in developed nations. It commonly arises from calcific degeneration in older adults or congenital bicuspid valves, though contributes worldwide, especially in Asia. , often rheumatic in origin, impacts about 55 million individuals as part of rheumatic heart disease as of 2025, with highest burdens in , , and due to group A Streptococcus infections. In the U.S., its prevalence is low at around 1 in 100,000, largely attributable to historical cases before widespread antibiotic use. Pulmonic and tricuspid stenoses are rarer, typically congenital, and less commonly detailed in epidemiological data. Pathognomonic features of include leaflet thickening, , and extensive , often asymmetrically distributed along the commissures, leading to restricted mobility and a reduced systolic . In rheumatic cases, commissural may also occur, though predominates in degenerative forms. For , hallmark signs involve commissural resulting in a "fish mouth" or funnel-shaped , leaflet thickening with , and chordal shortening or , producing a characteristic "" doming on . These features, driven by and in rheumatic , distinguish it from calcific processes. Clinically, valvular stenosis elevates transvalvular gradients, as the narrowed increases to , often exceeding 40 mmHg in severe aortic cases under . This obstruction reduces and overall , forcing compensatory left ventricular hypertrophy that eventually impairs contractility and risks . In , elevated left atrial gradients (>4 mmHg) hinder ventricular filling, similarly diminishing and promoting pulmonary congestion. These hemodynamic effects underscore the progressive burden on cardiac efficiency across affected valves.

Vascular Stenosis

Vascular stenosis refers to the abnormal narrowing of arteries or veins in the systemic circulation, distinct from cardiac valvular structures, which impedes blood flow and can lead to downstream ischemia. This condition primarily arises from atherosclerotic plaque buildup in arterial walls, though other mechanisms such as or external compression may contribute. In arteries, the narrowing reduces the vessel's cross-sectional area, often by 50% or more, significantly restricting oxygenated blood delivery to vital organs and extremities. Venous stenosis, while less prevalent, involves obstruction of venous return, causing and elevated pressure in affected regions. Arterial examples include , where plaque accumulates in the carotid arteries on either side of the neck, blocking blood flow to the brain, face, and head. This narrowing, often due to , increases the risk of ischemic by dislodging plaque fragments that occlude cerebral vessels. Renal artery stenosis similarly affects the supplying the kidneys, primarily from atherosclerotic plaques or , reducing oxygen-rich blood flow and impairing kidney function, which can manifest as from activated renin-angiotensin mechanisms. Peripheral artery disease exemplifies lower extremity involvement, with stenosis in arteries such as the femoral or popliteal due to atherosclerotic narrowing, limiting blood supply to the legs and causing from exercise-induced ischemia. A 50% reduction in vessel diameter can decrease cross-sectional area by 75%, severely compromising perfusion during activity when metabolic demands exceed available flow. Coronary artery stenosis, occurring in the vessels supplying the heart muscle, results from plaque buildup that restricts myocardial oxygen delivery, leading to ischemia and . Supravalvular aortic stenosis provides an example of narrowing in the above the valve, a congenital defect caused by ELN gene mutations that thicken the aortic wall, forcing the heart to pump harder against the obstruction and potentially causing systemic hypoperfusion. Venous stenosis is rarer but notable in , where the is obstructed, often by or thrombi from catheters, impairing venous drainage from the head, neck, and upper extremities, resulting in elevated venous pressure and congestion. The hemodynamic consequences of vascular stenosis center on altered flow dynamics, where luminal narrowing increases and at the stenosis site, but overall reduces volumetric flow to distal tissues, precipitating ischemia. In arteries, this mismatch between starves tissues of oxygen, promoting cellular damage, while in veins, backup of blood elevates hydrostatic pressure, fostering and impaired return to the heart. These effects underscore the circulatory impact, with severe stenoses (>70% in arteries) critically limiting reserve capacity and heightening risks of or failure.

Spinal Stenosis

Spinal stenosis refers to the abnormal narrowing of the or neural foramina within the , which can compress the , , or exiting nerve roots, leading to neurological dysfunction due to impaired . This condition primarily affects the spaces housing neural elements, where the extends from the to the L1-L2 level before transitioning to the , and nerve roots traverse foramina formed by pedicles, facets, and discs. The narrowing disrupts the normal cushioning and vascular supply to neural tissues, emphasizing the neuroanatomical vulnerability in the spinal canal's bony and soft tissue boundaries. Anatomically, spinal stenosis occurs at three main sites along the : the (), thoracic (mid-back), and (lower back) regions, with variations in prevalence and implications for neural compression. is the most common site, often involving the L4-L5 level, where the narrows below 12 mm (normal range: 15-27 mm), affecting the and nerve roots. typically arises in the C3-C7 segments, with an anteroposterior less than 10 mm considered stenotic (normal: 17-18 mm at C3-C5, decreasing caudally), potentially compressing the . Thoracic stenosis is rare, usually focal and involving a of 12-14 mm, impacting the relatively immobile thoracic cord with limited compensatory space. Within these sites, stenosis is classified as central, involving midline narrowing that affects the and central neural elements, or foraminal (lateral), where the intervertebral foramina (normally 3-4 mm wide) constrict, entrapping exiting nerve roots. The structural components contributing to spinal stenosis include degenerative changes in vertebrae, ligaments, and intervertebral discs, which encroach on the neural spaces. Vertebral elements, such as hypertrophy and formation from , protrude into the canal or foramina, reducing the available space for neural passage. Ligaments play a key role, with hypertrophy of the ligamentum flavum—the posterior band connecting laminae—thickening up to 5-6 mm (normal: 2-4 mm) and buckling during extension, while ossification of the (OPLL) rigidifies the anterior canal boundary. Intervertebral discs contribute through bulging or herniation, where the nucleus pulposus displaces the annulus fibrosus posteriorly or laterally, compressing the or roots, particularly in the region where disc height loss exacerbates foraminal narrowing. Lumbar spinal stenosis represents the most frequent presentation, often manifesting as , a hallmark symptom involving bilateral , , or weakness induced by upright and walking, due to dynamic compression of lumbosacral nerve roots during extension. This contrasts with presentations, which may include radiating to arms () from foraminal involvement or gait instability from cord compression, and thoracic cases, which are uncommon but can present with band-like or myelopathic signs from mid-cord irritation. arises from ischemia and mechanical deformation of nerve roots in the narrowed canal, distinguishing it from vascular claudication by relief with spinal flexion rather than rest alone. Spinal stenosis severity ranges from mild, often and incidental on in individuals over 60 years, to severe, where significant neural compromise leads to or . Mild cases involve less than 30% canal compromise without clinical deficits, while moderate severity (30-50% narrowing) may cause intermittent symptoms like limited walking distance (e.g., 50 feet). Severe stenosis, with over 50% reduction or diameter below 10 mm in critical areas, results in progressive —characterized by , , and bowel/bladder dysfunction in or thoracic sites—or motor weakness and in involvement. Grading systems, such as those based on MRI thecal sac cross-sectional area (<100 mm² for central stenosis), help quantify this progression and guide neuroanatomical assessment.

Other Anatomical Stenoses

Other anatomical stenoses encompass narrowings in diverse organ systems, resulting in localized obstructions that impair normal physiological functions such as swallowing, urination, respiration, and bile flow. These conditions often arise from congenital anomalies, inflammation, or iatrogenic injury, and their manifestations depend on the affected site. While less common than vascular or spinal variants, they require targeted diagnostic and therapeutic approaches to alleviate symptoms like pain, obstruction, or organ dysfunction. In the gastrointestinal tract, esophageal stenosis refers to an abnormal narrowing of the esophageal lumen, frequently causing dysphagia or difficulty swallowing solids and liquids due to mechanical obstruction. This condition can manifest as a sensation of food impaction and may lead to weight loss or aspiration if untreated. Pyloric stenosis, particularly in infants, involves hypertrophy of the pyloric muscle, narrowing the gastric outlet and resulting in forceful vomiting, dehydration, and failure to thrive as stomach contents fail to empty into the duodenum. Genitourinary stenoses include , characterized by scar tissue narrowing the urethral lumen, which obstructs urine flow and produces symptoms such as weak stream, urinary retention, recurrent infections, or pain during voiding. similarly involves luminal narrowing of the ureter, leading to upstream , flank pain, and potential renal impairment from impaired urine drainage to the bladder. These obstructions highlight the critical role of patency in maintaining urinary tract integrity. Respiratory tract stenoses, such as subglottic stenosis, entail narrowing of the airway below the vocal cords within the cricoid cartilage, often causing stridor, respiratory distress, or recurrent croup-like episodes, particularly in children where it may compromise airflow and oxygenation. Tracheal stenosis extends this obstruction to the trachea, resulting in wheezing, shortness of breath, and severe airflow limitation that can escalate to life-threatening respiratory failure if the narrowing exceeds 50% of the lumen. These conditions underscore the vulnerability of the upper airway to fibrotic or inflammatory changes. Biliary stenosis, notably of the common bile duct, presents as a narrowing that impedes bile flow from the liver to the intestine, leading to jaundice, pruritus, , or cholestatic liver injury due to bile accumulation. This functional impact disrupts digestion and increases risks of secondary infections or gallstone formation proximal to the stricture.

Pathophysiology

Mechanisms of Narrowing

Stenosis arises from multifaceted cellular processes that remodel and deposit materials within tubular structures, leading to progressive luminal narrowing. Inflammation plays a pivotal role, initiating the recruitment of immune cells such as monocytes and macrophages via endothelial activation and adhesion molecule expression, like and , which perpetuate tissue injury and remodeling. Fibrosis follows, as activated fibroblasts and myofibroblasts secrete excessive extracellular matrix components, including , resulting in scar-like tissue that stiffens and encroaches on the passageway. In valvular tissues, for instance, valvular interstitial cells differentiate into myofibroblasts under inflammatory cues, driving this fibrotic response. Hypertrophy contributes to narrowing by enlarging cellular components in response to mechanical stress or growth factors, such as TGF-β1, which promotes cell proliferation and matrix synthesis. In spinal structures, ligamentum flavum cells undergo hypertrophy through pathways involving inflammatory cytokines like IL-6, leading to thickened ligaments that compress the spinal canal. Calcification exacerbates this by depositing calcium phosphate crystals in damaged or apoptotic tissues, often nucleated by matrix vesicles, which rigidifies the structure and reduces compliance. These cellular events create a self-reinforcing cycle, where initial inflammation amplifies downstream fibrosis and calcification. Physical factors, including plaque accumulation and scar formation, directly impinge on the lumen. In vascular stenosis, atherosclerotic plaques build up through lipid retention, oxidation, and foam cell formation, forming a necrotic core overlain by a fibrous cap that progressively occludes the artery. Post-injury scar tissue, composed of dense collagen, similarly replaces functional tissue, as seen in various anatomical sites. The process typically originates from endothelial dysfunction, evolving over time into substantial narrowing; for example, arterial diameter reductions exceeding 70% are deemed critical, significantly compromising flow.

Hemodynamic Effects

Stenosis induces significant hemodynamic alterations by creating a pressure gradient across the narrowed segment, where upstream pressure elevates to maintain flow while downstream pressure drops, leading to inefficient perfusion. In valvular stenosis, such as , this gradient imposes a chronic pressure overload on the upstream chamber, prompting left ventricular hypertrophy as a compensatory adaptation to normalize wall stress according to the . This hypertrophy initially preserves cardiac output but can progress to maladaptive remodeling if unrelieved. Flow reduction distal to the stenosis often generates turbulence, particularly when the Reynolds number exceeds critical thresholds in moderate to severe cases, disrupting laminar flow patterns. This turbulence elevates wall shear stress at the stenosis site, which can exacerbate endothelial damage and promote further plaque progression or rupture in vascular stenoses. In coronary or carotid arteries, the resulting oscillatory shear stress contributes to atherogenesis by altering vascular cell signaling and integrity. Organ-specific impacts vary by location; in vascular stenosis like carotid artery narrowing, reduced distal flow can cause hemodynamic ischemia, impairing tissue oxygenation despite intact collaterals in some cases up to 90% stenosis severity. Conversely, valvular overload in leads to left ventricular strain, potentially culminating in systolic dysfunction from fibrosis. These effects underscore the progressive nature of stenosis on regional hemodynamics. In chronic stenosis, compensatory mechanisms such as collateral circulation development mitigate flow deficits; for instance, in carotid stenosis, recruitment of contralateral or posterior circulation pathways enhances perfusion to ischemic territories. This adaptation, driven by hemodynamic and metabolic signals, provides neuroprotection in intracranial stenoses by reducing stroke risk through augmented antegrade flow. However, collateral efficacy depends on stenosis chronicity and severity, with incomplete compensation risking decompensation under stress.

Causes

Congenital Causes

Congenital stenosis refers to narrowing of anatomical structures due to developmental abnormalities present at birth, often stemming from disruptions in embryonic tissue formation or genetic influences that affect . These conditions can involve valvular, vascular, or other structures and are typically identified as part of or urogenital malformations, though they remain rare overall with an estimated incidence of less than 1% in the general population for isolated cases. Genetic factors play a significant role in congenital stenosis, particularly through mutations in genes regulating cellular signaling and tissue differentiation during fetal development. For instance, mutations in the NOTCH1 gene, which encodes a receptor involved in cell-cell communication, have been linked to congenital aortic valve stenosis by impairing endocardial cushion formation and leading to abnormal valve leaflet development. These mutations are implicated in familial cases of , a common precursor to valvular stenosis, with NOTCH1 variants identified in pedigrees showing autosomal dominant inheritance with incomplete penetrance. Other genes, such as those in the , contribute to disrupted valve morphogenesis, increasing susceptibility to early calcification and narrowing. Embryological origins of congenital stenosis trace back to aberrant formation of endodermal and mesodermal tissues during early gestation, often around weeks 4-8 when cardiac septation and vascular arches develop. In valvular stenosis, incomplete fusion or excessive tissue proliferation in the endocardial cushions can result in malformed semilunar valves, such as the bicuspid aortic valve arising from failed septation of the . Vascular stenoses, like , stem from abnormal resorption of the or excessive ductal tissue invasion into the aortic wall near the isthmus, leading to localized narrowing. Similarly, in the urogenital tract, posterior urethral valves form due to incomplete regression of embryonic urogenital folds, obstructing urine flow and causing urethral stenosis. Specific examples illustrate the diversity of congenital stenoses. Bicuspid aortic valve, the most prevalent, affects 1-2% of the general population and predisposes to progressive through turbulent flow and leaflet stress. Congenital pulmonic stenosis, involving narrowing at the pulmonary valve or outflow tract, occurs in approximately 1 per 2,000 live births and often results from thickened valve cusps or subvalvular ridges. Coarctation of the aorta, a vascular example, accounts for 6-8% of all with an incidence of about 1 in 2,900 live births, typically presenting as juxtaductal narrowing. In infants, posterior urethral valves cause urethral stenosis in roughly 1 in 4,000 to 8,000 male births, leading to bladder outlet obstruction from membranous folds. These conditions highlight how localized embryological errors can yield functionally significant narrowing from birth.

Acquired Causes

Acquired causes of stenosis encompass a range of postnatal conditions that lead to the narrowing of anatomical passages through degenerative, inflammatory, traumatic, iatrogenic, or lifestyle-related mechanisms. These factors typically develop over time due to environmental exposures, injuries, or medical interventions, distinguishing them from congenital origins. In various anatomical sites, such as valves, vessels, and the spinal canal, acquired stenosis often progresses gradually, influenced by modifiable risk factors. Degenerative processes represent a primary acquired cause, particularly in older individuals, where age-related changes lead to tissue calcification and fibrosis. In valvular stenosis, calcific degeneration of the is the most prevalent form, characterized by progressive calcium deposition on valve leaflets, resulting in stiffness and narrowing; this process can remain asymptomatic for decades before clinical manifestation. Similarly, in vascular stenosis, atherosclerosis drives luminal narrowing through plaque buildup in arterial walls, commonly affecting , , and . For spinal stenosis, degenerative spondylosis—stemming from and disc degeneration—causes hypertrophy of ligaments, facet joints, and bone spurs, compressing the spinal canal. These degenerative changes are exacerbated by chronic mechanical stress and metabolic alterations, such as lipid accumulation. Inflammatory conditions also contribute significantly to acquired stenosis, often through immune-mediated damage to tissues. Rheumatic fever, a sequela of untreated streptococcal infection, is a leading cause of mitral valve stenosis worldwide, particularly in developing regions, where it triggers valvular fibrosis and fusion of commissures via an autoimmune response. In the airways, radiation therapy for thoracic malignancies can induce tracheal stenosis through fibrotic scarring and necrosis, typically emerging months to years post-exposure due to endothelial damage and chronic inflammation. Such inflammatory pathways may overlap with degenerative ones, as seen in , where low-grade inflammation promotes plaque instability. Traumatic injuries frequently result in acquired stenosis via scar tissue formation following acute damage. Post-surgical scarring, such as after prolonged endotracheal intubation, is a common cause of tracheal stenosis, where pressure from the tube cuff induces mucosal ischemia and subsequent cicatricial narrowing in up to 10-20% of prolonged cases. In the spine, trauma from fractures or herniations can lead to stenosis through callus formation and ligamentous thickening during healing. These traumatic sequelae highlight the role of wound healing dysregulation in perpetuating narrowing. Iatrogenic causes arise directly from medical procedures, leading to unintended strictures. For instance, restenosis following coronary angioplasty occurs in approximately 20-30% of cases due to neointimal hyperplasia and elastic recoil at the treated site, effectively creating a new stenosis. Similarly, procedural complications like vessel dissection during endovascular interventions can promote thrombus formation and subsequent narrowing. In transplant settings, iatrogenic arterial stenosis may develop from surgical anastomotic issues or post-procedural inflammation. Lifestyle factors play a crucial role in acquired vascular stenosis, particularly through modifiable risks that accelerate atherosclerosis. Smoking promotes endothelial dysfunction and plaque progression, increasing the risk of carotid and coronary stenosis by 2-4 fold in habitual users. Hyperlipidemia, characterized by elevated low-density lipoprotein levels, drives cholesterol deposition in arterial walls, a key initiator of atherosclerotic narrowing; managing it via statins can reduce stenosis progression by up to 30%. These lifestyle elements underscore the potential for prevention in acquired forms of the condition.

Clinical Presentation

Symptoms

Symptoms of stenosis manifest as patient-reported complaints arising from the narrowing of anatomical passages, leading to impaired flow and function in the affected system. These subjective experiences vary by location but commonly include sensations of discomfort, limitation, or distress tied to the reduced capacity of the structure. Cardiovascular symptoms often arise in cases of valvular or arterial narrowing, such as aortic stenosis, where patients describe exertional dyspnea due to increased cardiac workload and reduced cardiac output. For peripheral arterial stenosis, intermittent claudication is common, characterized by cramping or pain in the legs, buttocks, or hips during walking or exercise, which typically resolves with rest. Angina, characterized by chest pain or tightness, results from myocardial ischemia secondary to the obstruction. Syncope or near-fainting episodes may occur, particularly during physical activity, from transient cerebral hypoperfusion. Respiratory symptoms are characteristic of tracheal or subglottic stenosis, where patients report shortness of breath or dyspnea, especially with exertion or even at rest in severe cases, along with stridor—a high-pitched wheezing sound during breathing—and chronic cough. Neurological symptoms predominate in spinal stenosis, especially lumbar involvement, where individuals report radicular pain radiating along nerve roots into the legs, often worsening with prolonged standing or walking. Weakness in the lower extremities is a common complaint, accompanied by numbness or tingling in the back, buttocks, or limbs due to nerve compression. These sensations typically improve with rest or forward flexion. Gastrointestinal symptoms are prominent in esophageal stenosis, with dysphagia—the sensation of difficulty swallowing solids or liquids—being the hallmark report, often progressing from intermittent to persistent. Patients may also describe vomiting, particularly post-meal, or regurgitation of undigested food from esophageal obstruction. Genitourinary symptoms occur in urethral stenosis, or stricture, where affected individuals frequently report urinary hesitancy, a delay in starting urination due to the narrowed passage. Recurrent urinary tract infections are commonly noted, stemming from incomplete bladder emptying and stasis of urine. General symptoms across various stenoses include fatigue, attributed to systemic effects of reduced tissue perfusion and oxygenation, which limits daily activities and exacerbates with exertion. This pervasive tiredness reflects the body's compensatory response to chronic hypoperfusion in multiple organs.

Physical Signs

In valvular stenosis, such as , auscultation often reveals a systolic ejection murmur that radiates to the neck, along with a diminished or absent second heart sound (A2). Palpation may detect a slow-rising, late-peaking carotid pulse known as pulsus parvus et tardus, indicative of severe obstruction. As the condition progresses, signs of left ventricular failure, including jugular venous distension, bibasilar rales, and peripheral edema, become evident due to increased cardiac workload. Respiratory signs in tracheal stenosis may include audible stridor, a high-pitched inspiratory or biphasic sound heard over the trachea, and wheezing on auscultation of the chest, reflecting turbulent airflow through the narrowed airway. Vascular stenoses present with palpable pulse deficits and auscultatory bruits. In carotid artery stenosis, a bruit over the carotid may be heard on auscultation, reflecting turbulent flow through the narrowed lumen. For peripheral arterial stenosis, diminished or absent femoral, popliteal, or pedal pulses are common, often accompanied by cool skin, delayed capillary refill exceeding 2 seconds, and dependent rubor upon leg elevation. These findings correlate with reduced distal perfusion and ischemia risk. Spinal stenosis yields neurological signs on examination, varying by level affected. In lumbar stenosis, limited lumbar extension, lower extremity weakness, sensory deficits in dermatomal distributions, and hyporeflexia at the ankles may be observed, alongside a wide-based gait. Cervical stenosis often manifests with upper motor neuron signs, including hyperreflexia, spasticity, positive Babinski response, and Hoffman sign, due to cord compression. Focal motor weakness or clonus in the limbs further supports myelopathy. Gastrointestinal stenoses, such as , may show palpable abdominal findings. In infantile cases, an "olive-like" mass representing the hypertrophied pylorus can be felt in the right upper quadrant during relaxed examination. Adult hypertrophic pyloric stenosis occasionally presents with epigastric tenderness or a subtle mass on deep palpation, though these are less consistent. Succussion splash, elicited by rocking the abdomen, indicates gastric outlet obstruction.

Diagnosis

Imaging Modalities

Echocardiography serves as the cornerstone for evaluating valvular , providing detailed visualization of valve structure and function. Transthoracic echocardiography (TTE) is the initial noninvasive modality of choice, offering real-time imaging of valve leaflets, annuli, and chambers to assess morphological changes such as leaflet thickening or calcification in conditions like aortic or mitral . Transesophageal echocardiography (TEE) enhances resolution for posterior structures and is particularly useful when TTE images are suboptimal, such as in obese patients or those with poor acoustic windows, allowing precise evaluation of prosthetic valves or complex anatomy. Doppler echocardiography complements structural imaging by quantifying severity through measurement of transvalvular pressure gradients and valve areas; for instance, peak velocity and mean gradient calculations via continuous-wave Doppler are standard for grading aortic . TTE demonstrates high diagnostic accuracy for aortic detection when combining two-dimensional and Doppler techniques. For vascular stenosis, computed tomography (CT) angiography and magnetic resonance (MR) angiography provide comprehensive luminal assessment across arterial beds, from carotid to peripheral vessels. CT excels in rapid, high-resolution depiction of vessel narrowing, plaque composition, and collateral circulation, making it ideal for preoperative planning in carotid or renal artery stenosis; it achieves pooled sensitivity of 93% and specificity of 99% for severe internal carotid artery stenosis (>70%). MR , particularly contrast-enhanced time-of-flight sequences, offers excellent soft-tissue contrast without , effectively evaluating stenosis in vertebral or peripheral arteries, such as in carotid arteries with sensitivity up to 94% and specificity of 92% for high-grade lesions. In , MRI is the preferred modality for assessing narrowing and neural , visualizing dural sac area, facet , and ligamentum flavum thickening; it provides sensitivity of 87-96% and specificity of 68-75% compared to surgical findings. Duplex ultrasound is a frontline, noninvasive tool for peripheral and carotid vascular stenosis, combining B-mode imaging of vessel walls with spectral Doppler for velocity measurements to estimate degree of narrowing. In carotid stenosis, criteria such as peak systolic velocity ≥200 cm/s indicate ≥70% stenosis with of 90% and specificity of 94%. It is particularly valuable for serial monitoring due to its portability and lack of radiation. Plain and offer basic screening for airway and esophageal stenosis, particularly in acute settings. Frontal and lateral chest radiographs can reveal tracheal narrowing or deviation, while during (esophagram) dynamically assesses esophageal strictures by observing bolus passage and mucosal irregularities. These modalities are limited in quantification but guide further when dynamic collapse, as in , is suspected.

Functional Assessments

Functional assessments in stenosis evaluate the physiological consequences of narrowing on blood flow, , urine flow, or neural conduction, providing dynamic insights into performance that complement anatomical . These tests quantify , limitations, or provocations under to assess severity and guide , focusing on measurable impacts rather than static structure. Cardiac catheterization serves as an invasive method to directly measure pressure across stenotic heart valves, such as in , where a transvalvular gradient exceeding 40 mmHg indicates severe obstruction. During the , catheters are advanced to record simultaneous left ventricular and aortic pressures, calculating and peak gradients to evaluate hemodynamic significance when noninvasive estimates are inconclusive. This approach is particularly valuable in discrepant cases, as it provides precise pressure data for valve area calculation using the Gorlin formula, though it carries risks like arterial injury. Stress testing, often via treadmill exercise, provokes symptoms to assess functional limitations from stenosis, such as in or ischemia in coronary or . In spinal cases, patients walk until symptoms like leg pain or emerge, with walking distance and relief upon flexion quantifying dynamic ; a positive test reproduces in over 90% of confirmed cases preoperatively. For vascular stenosis, it induces ischemia to evaluate deficits, measuring time to symptom onset and recovery to gauge exercise tolerance. Pulmonary function tests (PFTs) detect limitation in tracheal stenosis by measuring spirometric parameters like forced expiratory in one second (FEV1) and , which decline disproportionately when obstruction exceeds 50-70% of tracheal diameter. Flow- loops often show flattening of the inspiratory or expiratory limb, indicating fixed upper airway narrowing, with reduced mid-expiratory flow rates reflecting turbulent flow dynamics. These tests are essential for quantifying severity and monitoring post-interventional changes, though interpretation requires correlation with symptoms as mild stenoses may not alter PFTs significantly. Urodynamic studies evaluate urethral stenosis by assessing urine rates and bladder pressures, with uroflowmetry revealing a reduced maximum (Qmax <15 mL/s) and prolonged voiding time due to obstructive narrowing. Pressure-flow analysis during voiding measures detrusor pressure at Qmax to distinguish fixed strictures from detrusor underactivity, confirming obstruction when elevated pressures accompany low flows. These metrics guide intervention thresholds, as strictures causing Qmax below 10 mL/s often warrant treatment to prevent complications like retention. Electrophysiological assessments, particularly electromyography (EMG), detect nerve root involvement in spinal stenosis by identifying denervation patterns in paraspinal and limb muscles, such as fibrillation potentials or reduced recruitment indicating chronic compression. Needle EMG localizes affected levels with high specificity, while nerve conduction studies rule out peripheral neuropathies; provocative testing during walking can exacerbate abnormalities in cases with neurogenic claudication. These findings confirm radiculopathy when imaging shows equivocal stenosis, aiding in distinguishing surgical candidates.

Management

Conservative Approaches

Conservative approaches to managing emphasize non-invasive strategies aimed at symptom relief, slowing disease progression, and mitigating associated risks, particularly in patients with mild disease or those at high risk for invasive procedures. These strategies are tailored to the type and location of , focusing on lifestyle interventions, pharmacotherapy, and regular monitoring to optimize outcomes without anatomical correction. In cardiovascular stenoses, such as , , or often driven by , lifestyle modifications form the cornerstone of management. Patients are advised to adopt a heart-healthy diet low in saturated fats and rich in fruits, vegetables, and whole grains to reduce cholesterol levels and plaque buildup; engage in supervised aerobic exercise programs, which can improve walking distance by approximately 50-100 meters in ; and pursue smoking cessation through counseling or pharmacotherapy, as quitting reduces cardiovascular events by up to 30%. These changes are particularly indicated for asymptomatic or mild cases to modify risk factors and enhance cardiovascular fitness. Pharmacotherapy targets underlying mechanisms and comorbidities in vascular stenoses. High-intensity statins, such as or , are recommended to lower low-density lipoprotein cholesterol by at least 50%, stabilize atherosclerotic plaques, and decrease major adverse cardiovascular events by 20-30% in peripheral and carotid artery disease. Antiplatelet agents like (75-325 mg daily) or reduce thrombotic risks by 23-25%, while blood pressure control with antihypertensives prevents further endothelial damage. For patients with and concurrent heart failure symptoms, diuretics, used cautiously at low doses with monitoring to avoid excessive preload reduction, may alleviate congestion and improve quality of life, though they do not alter valve pathology. These medications are prioritized for high-surgical-risk individuals or those with mild stenosis to manage symptoms and prevent complications. Regular monitoring is essential for asymptomatic stenoses across types to detect progression early. In severe asymptomatic aortic stenosis, transthoracic echocardiography is performed every 6-12 months to assess left ventricular function, valve gradients, and pulmonary pressures, with exercise testing if symptom status is unclear. For carotid or peripheral stenoses, serial clinical evaluations and ankle-brachial index measurements guide adjustments in therapy. This watchful waiting approach is suitable for mild cases or patients preferring to avoid interventions. For spinal stenosis, particularly lumbar, conservative management centers on physical therapy to alleviate pain and improve function. Programs include posture correction exercises, low-back stretching, core strengthening, and use of assistive devices like corsets or canes to reduce lumbar lordosis and enhance mobility, often leading to symptom improvement in 50-70% of mild cases. Weight loss is encouraged to decrease mechanical stress on the spine. Medications such as nonsteroidal anti-inflammatory drugs, acetaminophen, or gabapentinoids target radicular pain and inflammation, providing relief without addressing structural narrowing. These interventions are indicated for patients with mild symptoms or high surgical risks, with ongoing monitoring via clinical follow-up.

Interventional Therapies

Interventional therapies for stenosis encompass a range of invasive procedures designed to mechanically alleviate narrowing and restore physiological function, primarily through surgical decompression or endovascular expansion, often evaluated by a multidisciplinary . These approaches are typically reserved for cases where conservative management fails to control symptoms, with selection based on the stenosis location, severity, and patient comorbidities. Procedures are guided by prior diagnostic imaging to confirm the site and extent of narrowing. In valvular stenosis, balloon valvuloplasty serves as a percutaneous intervention to treat severe narrowing of heart valves, particularly pulmonary, mitral, or aortic. A catheter with an inflatable balloon is advanced via the femoral artery or vein to the stenotic valve, where inflation fractures calcified or fused leaflets, increasing the valve orifice and reducing transvalvular pressure gradients. This technique is indicated for symptomatic severe stenosis in patients with pliable, non-calcified valves, such as those with congenital pulmonary stenosis or rheumatic mitral disease, achieving immediate hemodynamic improvement in up to 80-90% of suitable cases. However, its durability is limited in heavily calcified valves, with restenosis occurring in 20-50% within 6-12 months, often necessitating repeat intervention or valve replacement. For aortic valvular stenosis, transcatheter aortic valve replacement (TAVR) represents a minimally invasive endovascular option, especially for high-surgical-risk patients. A bioprosthetic valve mounted on a balloon-expandable or self-expanding frame is delivered through a catheter, typically via the femoral artery, and deployed within the native stenotic valve to restore competent leaflet motion and outflow. Indicated for severe symptomatic aortic stenosis (aortic valve area less than 1 cm²) and select asymptomatic cases with severe high-gradient AS and low surgical risk per 2025 ESC/EACTS guidelines, TAVR has demonstrated superior outcomes to medical therapy alone, with 1-year survival rates exceeding 80% and significant symptom relief in most patients. Compared to open surgical replacement, it offers shorter recovery times but similar rates of major adverse events in intermediate-risk cohorts. Vascular stenosis, commonly affecting coronary or peripheral arteries, is addressed through angioplasty with stenting or surgical bypass. Percutaneous transluminal angioplasty involves inflating a balloon at the lesion site to compress plaque and widen the lumen, frequently followed by deployment of a mesh stent to scaffold the vessel and prevent elastic recoil. In coronary applications, drug-eluting stents release antiproliferative agents to inhibit neointimal hyperplasia, reducing restenosis to 5-10% at 1 year versus 20-30% with bare-metal stents. This approach is preferred for single-vessel disease or acute settings like myocardial infarction, restoring blood flow in over 90% of procedures. For more extensive coronary involvement, coronary artery bypass grafting surgically anastomoses a graft (e.g., internal mammary artery or saphenous vein) proximal to the stenosis, providing long-term patency rates of 85-95% at 10 years, though it carries higher perioperative morbidity than stenting. Spinal stenosis interventions focus on neural decompression to alleviate radiculopathy or myelopathy. Laminectomy entails surgical excision of the lamina and hypertrophic ligaments to enlarge the spinal canal, performed via open or minimally invasive techniques under general anesthesia. It is indicated for central canal stenosis causing intractable pain, weakness, or neurogenic claudication, with 70-80% of patients reporting sustained symptom improvement at 2 years post-procedure. Foraminotomy targets foraminal stenosis by resecting bone or soft tissue compressing nerve roots, often combined with laminectomy or as a standalone endoscopic procedure to widen the intervertebral foramen. This preserves more posterior stability than full laminectomy and achieves decompression in 85-90% of foraminal cases, particularly in the lumbar region. Other sites of stenosis benefit from site-specific dilational or stenting techniques. Esophageal stenosis, often due to strictures from inflammation or malignancy, is managed with endoscopic balloon dilation, where a guidewire is passed through the stricture followed by controlled balloon inflation to achieve a luminal diameter of 12-20 mm. This outpatient procedure yields dysphagia relief in 80-90% of benign cases after one to three sessions, with repeat dilations needed in 30-50% over time for recurrent narrowing. Ureteral stenosis, resulting from stones, tumors, or iatrogenic injury, is relieved by ureteral stenting, involving placement of a double-J tube via cystoscopy or antegrade nephrostomy to bridge the obstruction and facilitate urine drainage. Metallic or polymeric stents maintain patency in 70-85% of complex strictures for 6-12 months, serving as a bridge to definitive repair or palliation in malignant cases. These interventions carry inherent risks, including infection at access sites or operative fields, with reported rates of 0.5-5% across endovascular and surgical approaches, mitigated by prophylactic antibiotics. Restenosis remains a key concern, occurring in 10-20% of vascular stenting cases within the first year due to neointimal proliferation, though lower with drug-eluting devices; similar recurrence affects 20-40% of valvular valvuloplasties. Other complications encompass bleeding, vascular injury, arrhythmia, or nerve damage, with overall procedural mortality under 2-5% in contemporary series.

Prognosis

Outcomes by Type

Outcomes for stenosis vary significantly by type, reflecting differences in underlying pathophysiology, treatment options, and patient factors. In valvular stenosis, particularly severe aortic stenosis, untreated cases carry a grave prognosis, with approximately 50% of symptomatic patients succumbing within 2 to 3 years of symptom onset. Surgical or transcatheter aortic valve replacement dramatically improves survival, achieving rates exceeding 90% at 5 years in low-risk patients and approaching 93% overall in selected cohorts. These interventions not only extend life expectancy but also enhance quality of life by alleviating symptoms such as dyspnea and fatigue, with median survival ranging from 6 to 16 years depending on age at procedure. Vascular stenosis, exemplified by carotid artery disease, poses risks primarily through ischemic events. For symptomatic carotid stenosis exceeding 70%, the annual risk under medical management historically ranges from 5% to 10%, though with contemporary optimal medical therapy as of 2025, this has decreased to approximately 1-2% annually in many patients. This underscores the urgency of intervention like endarterectomy or stenting to further reduce this hazard in appropriate candidates. Post-treatment, symptom resolution is common, with many patients experiencing stabilized cerebral perfusion and improved neurological function, though quality-of-life metrics emphasize ongoing risk factor control to prevent recurrence. In asymptomatic cases with >70% stenosis, annual rates are lower at around 1-2%, but progression monitoring remains essential. Spinal stenosis outcomes focus on functional recovery, with surgical yielding symptom improvement in 70-80% of patients, particularly relief from and . Long-term quality-of-life assessments show sustained benefits, with up to 75% of patients maintaining improved mobility and reduced disability for 8-10 years post-surgery. may suffice for milder cases, but excels in severe stenosis, enhancing overall satisfaction and daily functioning. Prognostic factors such as advanced age and comorbidities profoundly influence outcomes across stenosis types. In valvular disease, older patients (>85 years) face higher (up to 3.5%) and reduced long-term survival compared to younger cohorts, while comorbidities like and renal impairment exacerbate risks. Similarly, in vascular stenosis, frailty and cardiovascular comorbidities elevate recurrence rates, with age >75 years correlating to poorer post-intervention recovery. For , prolonged preoperative symptoms and multiple comorbidities predict less pain relief and higher reoperation needs, emphasizing preoperative optimization. These elements collectively modulate survival and symptom trajectories, guiding personalized care. Long-term monitoring is crucial post-treatment to detect progression or complications early. For valvular stenosis, annual tracks valve function and , while vascular cases require serial like duplex every 6-12 months to assess restenosis. Spinal patients benefit from periodic clinical evaluations and at 1-2 year intervals to monitor for adjacent segment , ensuring sustained quality-of-life gains.

Complications

Untreated or progressive valvular stenosis, such as , can lead to severe cardiovascular complications including , which arises from and systolic dysfunction due to chronic pressure overload. Arrhythmias, particularly ventricular ones, are also common and contribute to hemodynamic instability in these patients. In symptomatic severe cases, the risk of sudden cardiac death escalates, with an annual incidence approaching 1-2% even in monitored settings, often linked to malignant arrhythmias or acute hemodynamic collapse. Vascular stenosis, exemplified by narrowing, predisposes individuals to ischemic events such as and through plaque rupture and , accounting for 8-15% of ischemic s. Additionally, the altered hemodynamics from ipsilateral stenosis can promote aneurysm formation by increasing shear stress on arterial walls, potentially leading to rupture and further . In severe , neurological complications emerge from prolonged compression, resulting in lower extremity and bowel or incontinence as part of , which can cause permanent deficits if not addressed promptly. These sequelae reflect irreversible axonal damage and demyelination in the affected spinal segments. Systemic effects of stenosis extend to involvement, where bilateral narrowing accelerates progression to through ischemic nephropathy and activation of the renin-angiotensin system, elevating end-stage renal disease risk. Esophageal stenosis similarly heightens susceptibility to , as facilitates recurrent microaspiration of oropharyngeal contents, leading to pulmonary infection and potential . Early intervention, such as in valvular cases or in vascular stenosis, significantly mitigates these complications by restoring normal flow dynamics and preventing downstream organ damage, with studies showing reduced event rates in proactively managed patients.

References

  1. [1]
    What is Stenosis (Stricture)? Types, Causes - Cleveland Clinic
    Sep 30, 2024 · Stenosis and stricture are medical terms that refer to the abnormal narrowing of any channel or passageway in your body.
  2. [2]
  3. [3]
    Stenosis - Etymology, Origin & Meaning
    Stenosis, from Greek stenos "narrow" + -osis, means pathological narrowing of a passage in anatomy, originating from medical Latin in 1846.
  4. [4]
    Stenosis / stricture - Clinical Anatomy Associates Inc.
    Apr 10, 2015 · [Stenosis] arises from the Greek [στενός] (stenos) meaning "narrow". Since the suffix [-osis] means "condition of", the word [stenosis] means a ...
  5. [5]
    Occlusion vs Stenosis: When To Use Each One In Writing?
    Aug 16, 2023 · Occlusion refers to the complete blockage of a blood vessel, which can prevent blood from flowing through the affected area altogether. Stenosis ...
  6. [6]
    Physiologic Distribution and Local Severity of CAD - JACC
    Aug 15, 2022 · The 2-dimensional characterization of coronary atherosclerotic disease consists of physiologic distribution (predominant focal vs diffuse) and ...
  7. [7]
    Aortic Stenosis in the Elderly: Disease Prevalence and Number of ...
    May 30, 2013 · The pooled prevalence of all AS in the elderly was 12.4% (95% confidence interval [CI]: 6.6% to 18.2%), and the prevalence of severe AS was 3.4% ...
  8. [8]
    The past, present and future of aortic stenosis treatment
    The prevalence of AS increases with age,2,10 rising from <50 cases per 100,000 in those aged 25–49 years to >1,300 cases per 100,000 in those aged 80 years or ...
  9. [9]
    Severe aortic stenosis: secular trends of incidence and outcomes
    Jun 1, 2024 · The incidence rate was 52.5 [49.4-55.8] per 100 000 patient-year, slightly higher in males vs. females and was almost unchanged after age and ...
  10. [10]
    Prevalence of lumbar spinal stenosis in general and clinical ...
    The mean prevalence, based on a clinical diagnosis of LSS in the general population, was 11% (95% CI 4-18%), 25% (95% CI 19-32%) in patients from primary care, ...
  11. [11]
    Spinal Stenosis: Practice Essentials, Anatomy, Pathophysiology
    May 17, 2024 · This represents about 1 per 1000 persons older than 65 years and about 5 of every 1000 persons older than 50 years. About 70 million Americans ...
  12. [12]
    Spinal stenosis prevalence and association with symptoms
    The prevalence of acquired, so-called “degenerative” lumbar stenosis has been suggested as ranging from 1.7 to 13.1% [1–3]. However, previously reported studies ...
  13. [13]
    Lumbar Spinal Stenosis - DynaMed
    Aug 2, 2025 · Incidence/Prevalence · 21%-30% for moderate stenosis. · 6%-7% for severe stenosis.
  14. [14]
    Epidemiology of atherosclerotic carotid artery disease - PubMed
    The prevalence of carotid stenosis in the general population is low (3%), and routine screening for carotid stenosis is not recommended in adults. Randomized ...
  15. [15]
    Prevalence of Asymptomatic Carotid Artery Stenosis in the General ...
    Prevalence of severe asymptomatic carotid stenosis ranged from 0.1% (0.0% to 0.3%) in men aged <50 years to 3.1% (1.7% to 5.3%) in men aged ≥80. For women, this ...
  16. [16]
    Carotid stenosis: what is the high-risk population? - PMC - NIH
    In this population-based study, the prevalence of >50% stenosis of the internal carotid artery was 7.4%. The prevalence of significant asymptomatic carotid ...
  17. [17]
    Sex Differences and Similarities in Valvular Heart Disease
    Feb 17, 2022 · Although men are still at higher risk of developing AS overall than women, AS is increasingly common in elderly women and the majority of AS ...
  18. [18]
    Race Differences in High-Grade Carotid Artery Stenosis | Stroke
    May 4, 2021 · Generally, Blacks and Hispanics had a lower prevalence of high-grade stenosis compared with Whites, while Native Americans had a higher prevalence.
  19. [19]
    Geographic variation in aortic stenosis treatment and outcomes ...
    Feb 8, 2024 · Wide regional variation in the treatment and outcomes of AS was observed but were largely unexplained by patient factors and healthcare ...
  20. [20]
    The prevalence of carotid artery stenosis varies significantly by race
    Nov 23, 2012 · The prevalence of CAS was 3.4% in females and 4.2% in males (P ≤ .001). Controlling for gender and age, there was marked variation in the ...
  21. [21]
    Smoking and hypertension: risk factors for carotid stenosis - PubMed
    It was concluded that cigarette smoking, especially if associated with hypertension, is a determinant risk factor for carotid stenosis and occlusion.
  22. [22]
    Cumulative effects of high cholesterol levels, high blood ... - PubMed
    Conclusions: Over the long term, high systolic blood pressure, high cholesterol levels, and smoking were associated with an increased risk of carotid stenosis ...
  23. [23]
    Association Between Cardiovascular Risk Factors and Aortic Stenosis
    Mar 20, 2017 · ... risk factors (hypertension, diabetes, dyslipidemia). Higher adjusted HRs indicate increased hazard for the development of aortic stenosis.
  24. [24]
    4 Heart Valves: What They Are and How They Work - Cleveland Clinic
    The human heart has four valves, aortic, mitral, pulmonary and tricuspid that control blood flow. As they open and close, they make the noise known as a ...Aortic Valve · Mitral Valve · Tricuspid Valve · What is the Pulmonary Valve?
  25. [25]
    Roles of Your Four Heart Valves
    May 23, 2024 · Tricuspid Valve. Has three leaflets or cusps. Separates the top right chamber (right atrium) from the bottom right chamber (right ventricle).
  26. [26]
    Valvular Heart Disease Epidemiology - PMC - NIH
    Jun 15, 2022 · Worldwide, rheumatic valve disease is the most common cause of ASVD and mitral valve involvement invariably accompanies rheumatic aortic valve ...
  27. [27]
    Aortic valve stenosis - Symptoms and causes - Mayo Clinic
    May 10, 2025 · In aortic valve stenosis, the valve is narrowed and doesn't open fully. This reduces or blocks blood flow from the heart to the aorta and to the rest of the ...
  28. [28]
    Mitral Valve Disease: Types, Symptoms and Treatment
    Rheumatic fever is the most common cause of mitral valve stenosis, especially among people born before 1943. Modern use of antibiotics to treat bacterial ...Overview · Symptoms And Causes · Living WithMissing: prevalence | Show results with:prevalence
  29. [29]
    3D Echocardiography for Rheumatic Heart Disease Analysis
    Jul 19, 2021 · Aortic Valve Stenosis​​ Rheumatic aortic valve disease can lead to commissural fusion, fibrosis, thickening and calcification of the leaflets, ...
  30. [30]
    Unraveling the Mechanisms of Valvular Heart Disease to Identify ...
    Jun 17, 2024 · The most common cause of mitral valve disease worldwide is rheumatic mitral stenosis. The mitral valve and the annular ring are also subject to ...
  31. [31]
    Carotid Artery Stenosis: Causes, Symptoms and Treatment
    Carotid artery stenosis happens when your carotid artery becomes blocked or narrow. This is from a build-up of plaque that blocks blood flow to your brain.Overview · Symptoms And Causes · Diagnosis And Tests
  32. [32]
    Peripheral Arterial Disease - StatPearls - NCBI Bookshelf - NIH
    Patients with peripheral arterial disease (PAD) have decreased lower extremity arterial perfusion which is commonly referred to as “poor circulation.
  33. [33]
    Renal artery stenosis - Symptoms and causes - Mayo Clinic
    Jul 12, 2025 · Renal artery stenosis is when one or more arteries that carry blood to the kidneys narrow. These are called the renal arteries.
  34. [34]
    Peripheral Artery Disease (PAD) - Cleveland Clinic
    Peripheral artery disease is when arteries in your limbs (usually your legs) are narrowed, limiting blood flow. This can cause pain and cramping when you're ...
  35. [35]
    Coronary Artery Disease - StatPearls - NCBI Bookshelf
    Oct 9, 2024 · Coronary artery disease (CAD) is a prevalent heart condition characterized by the buildup of atherosclerotic plaque within the arterial lumen.
  36. [36]
    Supravalvular aortic stenosis: MedlinePlus Genetics
    May 1, 2012 · Supravalvular aortic stenosis (SVAS) is a heart defect that develops before birth. This defect is a narrowing (stenosis) of the large blood vessel.
  37. [37]
    Superior Vena Cava Syndrome - StatPearls - NCBI Bookshelf - NIH
    Superior vena cava (SVC) syndrome is a collection of clinical signs and symptoms resulting from partial or complete obstruction of blood flow through the SVC.
  38. [38]
    Spinal stenosis | Radiology Reference Article | Radiopaedia.org
    Jun 28, 2024 · Spinal stenosis is a condition in which a portion of the spinal canal narrows to the point at which it can exert pressure on the nerves that travel through the ...Lumbar spinal stenosis (grading) · Lumbar canal stenosis · Cervical canal stenosis
  39. [39]
    Lumbar Spinal Stenosis - StatPearls - NCBI Bookshelf
    Jan 30, 2024 · Lumbar spinal stenosis (LSS) is the narrowing of the spinal canal in the lower back, specifically in the lumbar region.
  40. [40]
    Foraminal Stenosis: What It Is, Symptoms, Types & Treatments
    Mar 28, 2023 · Foraminal stenosis is a condition that happens when narrowing in parts of your spine causes compression of your spinal nerves.
  41. [41]
    Spinal Stenosis Clinical Presentation: History, Physical Examination
    May 17, 2024 · Patients with cervical stenosis usually present with cervical radiculopathy, with or without myelopathy. Typically, the condition involves the ...Missing: neuroanatomy | Show results with:neuroanatomy
  42. [42]
    Esophageal Stricture - StatPearls - NCBI Bookshelf - NIH
    An esophageal stricture is an abnormal narrowing of the esophageal lumen. It often presents with difficulty swallowing and has many potential etiologies.
  43. [43]
    Pyloric stenosis - Symptoms and causes - Mayo Clinic
    Dec 10, 2024 · Pyloric stenosis (pie-LOHR-ik stuh-NOH-sis) is a narrowing of the opening between the stomach and the small intestine.
  44. [44]
    Urethral Strictures - StatPearls - NCBI Bookshelf
    A urethral stricture is an abnormal narrowing of the urethra, typically caused by scar tissue, leading to obstructive urinary symptoms.
  45. [45]
    Ureteral Stricture - Medscape Reference
    Mar 15, 2024 · A ureteral stricture is characterized by a narrowing of the ureteral lumen, causing functional obstruction.
  46. [46]
    Subglottic Stenosis - StatPearls - NCBI Bookshelf
    Oct 30, 2023 · Subglottic stenosis is the narrowing of the airway and can either be congenital or acquired. The subglottis region is defined as the space extending from 1 cm ...
  47. [47]
    Laryngotracheal Stenosis - StatPearls - NCBI Bookshelf - NIH
    Laryngotracheal stenosis (LTS) is a narrowing of the upper airway between the larynx and the trachea with potentially devastating consequences.
  48. [48]
    Bile Duct Stricture - StatPearls - NCBI Bookshelf - NIH
    Apr 30, 2025 · Biliary strictures refer to narrowed intrahepatic or extrahepatic biliary ductal system segments. When narrowed, they impede the normal ...Etiology · History and Physical · Evaluation · Treatment / Management
  49. [49]
    Atherosclerosis - Mechanisms of Vascular Disease - NCBI Bookshelf
    Atherosclerosis is an inflammatory disease that is initiated by multiple risk factors, including hypercholesterolemia, oxidized-LDL, altered biomechanical ...Atherosclerotic Lesions · Plaque Or Atheroma · Hypercholesterolemia And...
  50. [50]
    Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms
    Pro-calcific and anti-calcific signaling during the progression of CAVS. Activation of pro-osteogenic signaling cascades is thought to be a central mechanism ...
  51. [51]
    Ligamentum flavum fibrosis and hypertrophy: Molecular pathways ...
    Jul 1, 2020 · The accumulation and formation of inflammation-related fibrosis tissue is an important pathological mechanism for LF hypertrophy. Beyond ...
  52. [52]
    Asymptomatic Carotid Stenosis: Several Guidelines with Unclear ...
    [1] Although the presence of 50%–69% narrowing is considered as moderate stenosis, narrowing ≥70% is generally considered as severe stenosis.
  53. [53]
    Is left ventricular hypertrophy a friend or foe of patients with aortic ...
    Left ventricular hypertrophy (LVH) is traditionally considered a physiological compensatory response to LV pressure overload, such as hypertension and aortic ...
  54. [54]
    Impact of Aortic Valve Stenosis on Coronary Hemodynamics and the ...
    Aug 5, 2015 · Aortic valve stenosis (AS) induces compensatory alterations in left ventricular hemodynamics, leading to physiological and pathological ...
  55. [55]
    Wall shear stress and pressure patterns in aortic stenosis patients ...
    The elevated wall shear stress in a turbulent flow environment has since been used as an important risk stratification parameter in numerous studies involving ...
  56. [56]
    Turbulent blood flow plays an essential localizing role in the ... - NIH
    Our findings clearly demonstrated that the combination of turbulent blood flow and low wall shear stress (WSS) in the presence of hypercholesterolaemia and ...
  57. [57]
    The hemodynamic effects of internal carotid artery stenosis and ...
    The study suggests that while hemodynamic ischemia develops with carotid artery occlusion, it does not occur with even a 90% carotid artery stenosis or in ...
  58. [58]
    Aortic Stenosis, a Left Ventricular Disease: Insights from Advanced ...
    Jul 6, 2016 · The transition from left ventricular hypertrophy to fibrosis results in the eventual adverse effects on systolic and diastolic function.
  59. [59]
    Blood Flow Lateralization and Collateral Compensatory ...
    Apr 4, 2019 · The aim of this study was to quantify the hemodynamic disturbance and the compensatory pattern of collateral flow in patients with symptomatic carotid stenosis.Missing: chronic | Show results with:chronic
  60. [60]
    COLLATERALS & STROKE RISK IN INTRACRANIAL STENOSIS
    Collateral circulation is a potent determinant of stroke risk in intracranial atherosclerosis, demonstrating a protective role with severe stenoses.
  61. [61]
    Collateral Circulation | Stroke - American Heart Association Journals
    The opening of collaterals likely depends on several compensatory hemodynamic, metabolic, and neural mechanisms. Angiogenesis may stimulate collateral growth at ...
  62. [62]
    Coarctation of the Aorta - StatPearls - NCBI Bookshelf - NIH
    Coarctation of the aorta is a congenital condition characterized by the narrowing of the aortic arch, typically located just beyond the left subclavian artery.Epidemiology · Treatment / Management · Differential Diagnosis · Complications
  63. [63]
    Pulmonary Valve Stenosis: From Diagnosis to Current Management ...
    Jun 30, 2023 · Pulmonary stenosis (PS) is almost always congenital in origin. Isolated PS is a rare condition that occurs in about 1 per 2000 live births ...
  64. [64]
    NOTCH Signaling in Aortic Valve Development and Calcific Aortic ...
    The NOTCH1 mutations are the first identified human genetic variants that cause congenital bicuspid aortic valve (BAV) and calcific aortic valve disease (CAVD).
  65. [65]
    A novel NOTCH1 nonsense variant in a bicuspid aortic valve family ...
    Sep 29, 2025 · BAV is one of the most common congenital aortic valve malformations. NOTCH1 variants have been identified in three familial pedigrees with ...
  66. [66]
    Genetic and Developmental Contributors to Aortic Stenosis
    Apr 29, 2021 · This review summarizes our current understandings of AS cause; beginning with developmental origins of congenital valve disease, and leading into the ...
  67. [67]
    Congenital aortic valve stenosis: from pathophysiology to molecular ...
    Apr 28, 2023 · Congenital aortic valve stenosis (AVS) has an incidence of 3.8–4.9 per 10,000 live births, representing ∼3%–6% of all CHD (1–3). Congenital AVS ...
  68. [68]
    Bicuspid Aortic Valve - Cleveland Clinic
    About 1% to 2% of the general population has a bicuspid aortic valve. It's twice as common in men than it is in women. People with Turner syndrome have an ...
  69. [69]
    Bicuspid Aortic Valve: Background, Pathophysiology, Epidemiology
    Jun 30, 2025 · Bicuspid aortic valves may be present in as many as 1-2% of the population. Because the bicuspid valve may be entirely silent during infancy, ...
  70. [70]
    Posterior Urethral Valves - StatPearls - NCBI Bookshelf
    Posterior urethral valves are a rare congenital disorder affecting the male urinary tract, characterized by abnormal membranous folds in the posterior urethra.
  71. [71]
    Posterior Urethral Valves - Medscape Reference
    Mar 22, 2024 · PUVs are the cause of renal insufficiency in approximately 10-15% of children undergoing renal transplant. Approximately 15% of boys with PUVs ...Practice Essentials · Pathophysiology · Etiology · Epidemiology
  72. [72]
    Spinal Stenosis and Neurogenic Claudication - StatPearls - NCBI
    Spinal stenosis is a condition that is caused by the narrowing of the central canal, the lateral recess, or neural foramen. It can cause significant discomfort, ...Spinal Stenosis And... · Pathophysiology · Treatment / Management
  73. [73]
    Heart Valve Diseases - Causes and Risk Factors - NHLBI
    Mar 24, 2022 · Heart valve diseases can either be present at birth (congenital) or acquired over time from another disorder or event such as an injury or ...
  74. [74]
    Acquired aortic stenosis - PubMed
    The most common cause of acquired aortic stenosis is calcific degeneration, characterized by a slowly progressive, asymptomatic period which can last decades.
  75. [75]
    Renal Artery Stenosis - StatPearls - NCBI Bookshelf
    Renal artery stenosis is narrowing of the one or both of renal arteries. It is the major cause of hypertension.Pathophysiology · History and Physical · Evaluation · Treatment / Management
  76. [76]
    Spinal stenosis - Symptoms and causes - Mayo Clinic
    Jun 27, 2024 · Spinal stenosis happens when the space inside the backbone is too small. This can put pressure on the spinal cord and nerves that travel through the spine.Diagnosis and treatment · Laminectomy · Cervical laminectomy · Laminoplasty
  77. [77]
    Mitral valve stenosis - Symptoms and causes - Mayo Clinic
    Sep 4, 2024 · Causes of mitral valve stenosis include: Rheumatic fever. This complication of strep throat is the most common cause of mitral valve stenosis.
  78. [78]
    Radiation-Associated Airway Necrosis - PMC - NIH
    Fibrosis, necrosis, and, eventually, stenosis of the airway usually develop months to years after exposure to radiation treatment.
  79. [79]
    Pathophysiology and treatment of atherosclerosis - NIH
    Hypercholesterolaemia is considered one of the main triggers of atherosclerosis. The increase in plasma cholesterol levels results in changes of the arterial ...Lipoprotein Modification... · Current View · Hmg-Coa Reductase Inhibitors...
  80. [80]
    Iatrogenic subglottic tracheal stenosis after tracheostomy and ... - NIH
    Apr 14, 2019 · Tracheostomy and endotracheal intubation can result in subglottic tracheal stenosis, and predisposition to keloid scar formation can increase ...
  81. [81]
    Angioplasty - StatPearls - NCBI Bookshelf - NIH
    In-stent restenosis (ISR) is defined as the reduction in vascular luminal diameter after percutaneous intervention (PCI).
  82. [82]
    Restenosis following coronary angioplasty: clinical ... - PubMed
    Most studies now define angiographic restenosis as either a > 50% loss of initial gain or an absolute lesion stenosis of > or = 50% at follow-up angiogram.
  83. [83]
    Iatrogenic-Related Transplant Injuries: The Role of the Interventional ...
    Typical complications may be vascular or nonvascular. Vascular complications include arterial stenosis, graft thrombosis, and development of fistulae.
  84. [84]
    Large Artery Atherosclerosis: Carotid Stenosis, Vertebral ... - NIH
    In the Framingham Heart study, the degree of stenosis was predicted by common baseline atherosclerotic risk factors such as older age, cigarette smoking, ...Missing: acquired | Show results with:acquired
  85. [85]
    Aortic Stenosis Overview | American Heart Association
    May 23, 2024 · Causes of aortic stenosis​​ Aortic stenosis mainly affects older people as a result of scarring and calcium buildup in the valve cusp (flap or ...What Is Aortic Valve... · Causes Of Aortic Stenosis · What Treatments Are...<|separator|>
  86. [86]
    Spinal stenosis: MedlinePlus Medical Encyclopedia
    Aug 27, 2024 · Symptoms · Numbness, cramping, or pain in the back, buttocks, thighs, or calves, or in the neck, shoulders, or arms · Weakness of part of a leg or ...
  87. [87]
    Esophageal stricture - benign: MedlinePlus Medical Encyclopedia
    Oct 30, 2024 · Benign esophageal stricture is a narrowing of the esophagus (the tube from the mouth to the stomach). It causes swallowing difficulties.
  88. [88]
    Characteristics and management of congenital esophageal stenosis
    Dec 1, 2013 · In the 40 other patients, at diagnosis, 50% presented with dysphasia, 40% with vomiting, 50% with food impaction, and 42% with respiratory ...Clinical Symptoms At... · Diagnosis Of Ces · Discussion
  89. [89]
    Urethral stricture - Symptoms and causes - Mayo Clinic
    Oct 14, 2023 · Overview. A urethral (u-REE-thrul) stricture involves scarring that narrows the tube that carries urine out of the body, called the urethra.
  90. [90]
    Aortic valve disease - Symptoms and causes - Mayo Clinic
    Sep 27, 2023 · Symptoms · Chest pain or tightness. · Dizziness. · Fainting. · Fatigue after activity or having less ability to be active. · Irregular heartbeat.
  91. [91]
    Aortic Stenosis - StatPearls - NCBI Bookshelf - NIH
    Aortic stenosis is a common valvular disorder, especially in the elderly population, causing left ventricular outflow obstruction.Missing: general | Show results with:general
  92. [92]
    Bedside Physical Examination for the Diagnosis of Aortic Stenosis
    Figure 1. · Delayed carotid upstroke · Diminished second heart sound · Systolic murmur radiating to the neck · Late-peaking systolic ejection murmurs.
  93. [93]
    Carotid Artery Disease - MedlinePlus
    Jun 29, 2025 · One sign may be a bruit (whooshing sound) that your doctor hears when listening to your artery with a stethoscope. Another sign is a transient ...
  94. [94]
    Clinical Assessment of Peripheral Arterial Disease in the Office - NIH
    Physical examination findings suggestive of PAD include abnormal pulses, audible bruits, nonhealing lower extremity wounds, lower extremity gangrene, elevation ...
  95. [95]
    Lumbar Spinal Stenosis - PMC - PubMed Central - NIH
    In addition to pain, leg symptoms can include fatigue, heaviness, weakness and/or paresthesia. Patients with LSS also can report nocturnal leg cramps(28) and ...
  96. [96]
    Cervical Myelopathy - StatPearls - NCBI Bookshelf - NIH
    Aug 2, 2025 · If myelopathy ensues, management should follow the recommendations for mild, moderate, or severe DCM based on the mJOA grading score.
  97. [97]
    Degenerative Cervical Spinal Stenosis - PubMed Central - NIH
    Spasticity, enhanced reflexes and pyramidal tract symptoms are characteristics of this disease, while muscular fasciculation is regarded as untypical. The ...
  98. [98]
    Pyloric stenosis - Diagnosis and treatment - Mayo Clinic
    Dec 10, 2024 · In this condition, a valve between an infant's stomach and small intestine fails to open enough for food to pass through.
  99. [99]
    Diagnostic accuracy of palpation and ultrasonography for ... - NIH
    Physical examination may consist of careful palpation of the abdomen to search for pyloric thickening ('olive sign') and visualization of peristaltic waves.
  100. [100]
    Gastric Outlet Obstruction - StatPearls - NCBI Bookshelf
    Feb 15, 2025 · Patients typically present with epigastric abdominal pain or postprandial nausea and vomiting as their chief complaints.[3][10] Acute onset of ...
  101. [101]
    [PDF] Recommendations on the Echocardiographic Assessment of Aortic ...
    Apr 20, 2017 · Echocardiography is the key tool for the diagnosis and evaluation of aortic stenosis. Because clinical decision- making is based on the ...
  102. [102]
    Cardiac imaging in valvular heart disease - PMC - PubMed Central
    TTE is the first-line cardiac imaging modality for right-sided VHD, specifically for structural assessment of valve leaflets (Figure 9). Pathological tricuspid ...
  103. [103]
    Multimodality Imaging Strategies for the Assessment of Aortic Stenosis
    Feb 10, 2016 · (2) Transthoracic Doppler echocardiography is the first imaging approach to evaluate AS severity and is sufficient for an accurate diagnosis and ...
  104. [104]
    Aortic Stenosis Workup - Medscape Reference
    Nov 18, 2021 · Two-dimensional and Doppler echocardiography is the imaging modality of choice to diagnose and determine the severity of aortic stenosis.<|control11|><|separator|>
  105. [105]
    Systematic review and meta-analysis of the diagnostic value of ...
    Aug 14, 2024 · The meta-analysis revealed that the combined sensitivity and specificity of CTA for severe ICA stenosis were 0.93 (95% CI: 0.88 ~ 0.96) and 0.99 ...
  106. [106]
    meta-analysis with metaregression of different techniques - PMC
    According to two current meta-analyses, carotid CE-MRA has a high sensitivity of about 94% and a high specificity of about 92% for the diagnosis of severe ...
  107. [107]
    Magnetic resonance imaging for diagnosing lumbar spinal ... - NIH
    Spinal stenosis​​ Both studies showed high sensitivities of 87 and 96% coupled with lower specificities of 68 and 75%. Since this group only consisted of two ...
  108. [108]
    Spinal Stenosis Imaging - Medscape Reference
    Nov 30, 2022 · MRI of the spine is the more sensitive and specific study and is preferred in most cases. CT of the spine remains the primary means of diagnosis ...
  109. [109]
    Sensitivity and specificity of color duplex ultrasound measurement in ...
    For the diagnosis of angiographic stenosis of ≥70%, a peak systolic velocity ≥200 cm/s has a sensitivity of 90% (95% CI, 84% to 94%) and a specificity of 94% ( ...
  110. [110]
    Imaging Evaluation of Laryngotracheal Stenosis | RadioGraphics
    Jul 10, 2025 · Imaging reveals thickening of the submucosa, primarily affecting the entire trachea, and the submucosal tracheal wall shows concentric, smooth, ...
  111. [111]
    Tracheomalacia Workup: Imaging Studies, Endoscopy, Other Tests
    Jan 22, 2024 · In addition to showing collapse of the tracheal wall, cinefluoroscopy may identify esophageal defects, and it may reveal deformation of tracheal ...
  112. [112]
    Electrodiagnostic Evaluation of Spinal Stenosis - StatPearls - NCBI
    Aug 28, 2023 · Electrodiagnostic studies are performed especially in spinal stenosis because it helps the clinician to exactly localize and rule out other differentials.
  113. [113]
    Invasive assessment of aortic stenosis in contemporary practice - PMC
    While catheterization allows for direct measurement of pressure drop, Doppler echocardiography measures velocities that are converted into pressure drops. This ...
  114. [114]
    Discrepancies Between Direct Catheter and Echocardiography ...
    Current guidelines discourage aortic stenosis (AS) evaluation by invasive pressure measurement if echocardiography (echo) is adequate, but several studies ...
  115. [115]
    The diagnostic value of a treadmill test in predicting lumbar spinal ...
    The treadmill test helps objectifying pre- and postsurgical clinical complaints and verifying a lumbar spinal stenosis by creating a situation of dynamic strain ...
  116. [116]
    A comprehensive study of patients with surgically treated lumbar ...
    Conclusions: A positive treadmill test was consistent with a diagnosis of spinal stenosis and neurogenic claudication in >90% of the patients preoperatively.
  117. [117]
    Evaluation of the Tracheal Stenosis Effects on Airway Resistance ...
    Tracheal stenosis (TS) is a narrowing of the endotracheal lumen caused by trauma during surgery or in intensive care units, infection, tumor, or aspirated ...
  118. [118]
    Structure and function in tracheal stenosis - PubMed
    The mechanism of airflow obstruction was investigated in 21 patients with tracheal stenosis using tantalung tracheograms and pulmonary function studies, ...
  119. [119]
    Urodynamic Testing and Interpretation - StatPearls - NCBI Bookshelf
    Uroflowmetry assesses flow pattern, flow curve shape, maximum urinary flow (Qmax), voided volume (VV), voiding time (VT), PVR volume (PVR). A minimum of 150ml ...Introduction · Specimen Collection · Procedures · Potential Diagnosis
  120. [120]
    Urethral Stricture - AUA Guideline - American Urological Association
    Patients with symptomatic urethral stricture typically have a reduced peak flow rate.19, 20 Confirmation of a urethral stricture diagnosis is made with ...
  121. [121]
    Findings of Electrodiagnostic Studies in Moderate to Severe Lumbar ...
    We think that an electrodiagnostic study can be useful for evaluating the degree of nerve root damage by spinal stenosis.
  122. [122]
    None
    Nothing is retrieved...<|separator|>
  123. [123]
    Evidence-Based Medical Management of Peripheral Artery Disease
    Jan 30, 2020 · Moderate-intensity statin therapy with simvastatin reduced peripheral vascular events (defined as noncoronary revascularization, amputation, ...
  124. [124]
    Optimal Medical Management of Asymptomatic Carotid Stenosis
    May 5, 2021 · Optimal Medical Therapy: Lifestyle Modification · Diet · Exercise · Smoking · Antithrombotic therapy · ASA 75–325 mg/d · ASA+rivaroxaban 2.5 mg bid.
  125. [125]
    Nonsurgical treatment options for lumbar spinal stenosis - Mayo Clinic
    Jun 10, 2022 · Management options for LSS include watchful waiting, physical therapy, equipment and modalities, medications, injections, and surgical referral.Missing: guidelines | Show results with:guidelines
  126. [126]
    Balloon Valvuloplasty - StatPearls - NCBI Bookshelf
    Balloon valvuloplasty is a cardiac intervention to open up a stenotic or stiffed heart valves (eg, aortic or mitral) using a catheter with a balloon on the tip.Missing: interventional | Show results with:interventional
  127. [127]
    Transcatheter aortic valve replacement (TAVR) - Mayo Clinic
    Aug 12, 2025 · Transcatheter aortic valve replacement, also called TAVR, is a treatment to replace a narrowed aortic valve that doesn't open fully.
  128. [128]
    Coronary angioplasty and stents - Mayo Clinic
    Nov 7, 2023 · Coronary angioplasty and stent placement can greatly increase blood flow through a previously blocked or narrowed heart artery.
  129. [129]
    Coronary In-Stent Restenosis: JACC State-of-the-Art Review - PubMed
    Jul 26, 2022 · However, the incidence of in-stent restenosis (ISR) and the resultant need for repeated revascularization still occur at a rate of 1%-2% per ...
  130. [130]
    Stenting versus surgical bypass grafting for coronary artery disease
    Angioplasty with stenting compares favourably with CABG in terms of overall survival and freedom from MI or stroke. However, angioplasty with stenting is ...
  131. [131]
    Laminectomy - Mayo Clinic
    Jul 25, 2024 · Laminectomy is surgery to remove the back arch or part of a spinal bone. This part of the bone, called the lamina, covers the spinal canal.Missing: foraminotomy | Show results with:foraminotomy
  132. [132]
    Foraminotomy: MedlinePlus Medical Encyclopedia
    ### Summary of Foraminotomy for Spinal Stenosis
  133. [133]
    Fluoroscopically Guided Balloon Dilation of the Esophagus - NIH
    Fluoroscopically guided balloon dilation is a safe and effective procedure that can play an important role in the treatment of strictures and other conditions ...Missing: stenosis | Show results with:stenosis
  134. [134]
    Metal ureteral stents for ureteral stricture: 2 years of experience with ...
    Abstract. Background: Metal ureteral stents (MUS) has gained popularity as an endoscopic treatment alternative for the management of ureteral strictures.
  135. [135]
    Infectious complications of endoarterial interventional radiology
    Jun 3, 2019 · Malavaud et al have estimated the risk as 0.64% for coronary angioplasty and 4.9% for all arterial and venous angioplasties. Other studies have ...
  136. [136]
    Restenosis of Stented Coronary Arteries - StatPearls - NCBI Bookshelf
    Complications of restenosis include stable angina, unstable angina, acute coronary syndrome, acute myocardial infarction, or death. Revascularization procedures ...
  137. [137]
    [PDF] Explaining Risk to Patients with Severe Aortic Stenosis
    Mar 27, 2020 · From the onset of symptoms and if left untreated, approximately 50 out of 100 people (50%) will die within 2 to 3 years.
  138. [138]
    Survival After Surgical Aortic Valve Replacement in Low-Risk Patients
    Oct 17, 2023 · The results of this national study confirm that long-term survival after SAVR remains excellent, at 92.9% at 5 years.
  139. [139]
    Life Expectancy After Surgical Aortic Valve Replacement - JACC
    In low-risk patients, median survival time ranged from 16.2 years in patients aged 60 to 64 years to 6.1 years in patients aged ≥85 years. Age was associated ...
  140. [140]
    How Recent Data Have Impacted the Treatment of Internal Carotid ...
    Mar 16, 2015 · On the other hand, symptomatic carotid stenosis over 70% carries an annual stroke risk of 10% to 15%, based on 1990s medical therapy (4).
  141. [141]
    Asymptomatic carotid artery stenosis: a summary of current state of ...
    The latest 2014 American Heart Association (AHA) guidelines for aCAS recommend consideration of carotid endarterectomy (CEA) in ≥70% stenoses, yet highlight ...
  142. [142]
    What Is the Success Rate of Surgery for Spinal Stenosis?
    Spinal stenosis surgery has an 85% and 90% success rate in patients with lumbar spinal stenosis. About 75% of patients experience long-term outcomes for up ...<|separator|>
  143. [143]
    8 to 10 year results from the maine lumbar spine study - PubMed
    After 8 to 10 years, a similar percentage of surgical and nonsurgical patients reported that their low back pain was improved(53% vs. 50%, P = 0.8), their ...
  144. [144]
    Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis
    Feb 21, 2008 · Surgery for spinal stenosis is widely performed, but its effectiveness as compared with nonsurgical treatment has not been shown in controlled trials.
  145. [145]
    The Prognosis of Elderly Patients with Aortic Stenosis after ... - NIH
    The 30-day mortality was worse in patients ≥85 years old than in younger ones (0.7% vs. 3.5%, p=0.042). While there was no significant difference in the long- ...
  146. [146]
    Prognostic factors in lumbar spinal stenosis surgery - PubMed Central
    Oct 22, 2012 · Multiple factors predict outcome in spinal stenosis surgery, most importantly duration of symptoms and preoperative function.Missing: valvular | Show results with:valvular
  147. [147]
    Spinal Stenosis Treatment & Management - Medscape Reference
    May 17, 2024 · Long-term Monitoring. Inpatient care is necessary for patients with lumbar spinal stenosis (LSS) who elect to undergo surgery. The length of ...
  148. [148]
    Ventricular Arrhythmias in Severe Aortic Stenosis Prior to ... - NIH
    Apr 14, 2025 · Sudden death in AS is presumed to be arrhythmic in many cases, and studies consistently show that symptomatic severe AS patients have a high ...
  149. [149]
    Sudden Death in Patients With Severe Aortic Stenosis
    May 18, 2018 · The annual incidence of sudden death has been reported to be low (<1%/year) in asymptomatic patients with severe aortic stenosis (AS).
  150. [150]
    Risk-Stratification and Management of Extracranial Carotid Artery ...
    Based on current guidelines, patients with severe symptomatic stenosis should be referred for carotid endarterectomy (CEA) if the peri-operative risk is less ...
  151. [151]
    Multiple aneurysms coexisting with carotid occlusion revealed ... - NIH
    It is believed that ipsilateral stenosis aneurysms are linked to increased flow and speed of blood circulation, which exert stress on the walls of the arterial ...
  152. [152]
    Lumbar Spinal Stenosis: Pathophysiology, Biomechanics, and ...
    Lumbar spinal stenosis is most commonly caused by age-related osteoarthritic changes such as spondylosis with varying severities depending on the ...
  153. [153]
    A Case of Cauda Equina Syndrome With Delayed Diagnosis and ...
    Oct 3, 2025 · Failure to recognise CES or delays in surgical management can lead to irreversible complications, including paralysis of the lower limbs, ...
  154. [154]
    Early Aortic Valve Replacement of Asymptomatic Severe Aortic ...
    Aug 20, 2025 · Early intervention should be considered in asymptomatic patients with severe aortic stenosis to prevent the onset of symptoms and reduce the ...
  155. [155]
    Evidence-Based Carotid Interventions for Stroke Prevention - NIH
    Interventions, such as carotid end-arterectomy and carotid stenting, effectively reduce the risk of stroke in selected individuals.